Company intelligence / Profile preview

Innoheart

Singapore, Singapore

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Innoheart is a specialized preclinical contract research organization (CRO) based in Singapore that focuses on cardiovascular research and medical device evaluation. The company provides GLP-compliant services, including large animal surgical models, safety and efficacy testing, and comprehensive histopathology for innovative medical technologies. Innoheart supports global clients in the development of heart valves, stents, and other cardiovascular implants. Their facilities are designed to bridge the gap between benchtop testing and clinical trials through rigorous preclinical validation.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Contract Research Organization

Beyond the preview

Go deeper on Innoheart.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innoheart.

Explore the full profile